Journal of pediatric and adolescent gynecology · 2025
Non-Ablative Radiofrequency and Vaginal Dilation Therapy.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Ramalho Ana Maria Luna, Takano Claudia Cristina, Leite Mila Torii Corrêa, Sartori Marair Gracio Ferreira
Аннотация
INTRODUCTION: Radiofrequency (RF) is indicated for degenerative processes that involve decreased or delayed metabolism, blood flow, and nutrition, typically associated with chronic conditions. This study evaluated the effects of non-ablative radiofrequency (RF) combined with vaginal dilation in patients with vaginal agenesis or vaginal stenosis.
METHODS: Ten patients were divided into 2 groups: 5 received RF combined with dilation (VD+RF group), and 5 underwent only vaginal dilation (VD group). The RF treatment involved applying radiofrequency at 39°C for 5 minutes before dilation, while the VD group had dilation alone for 20 minutes.
RESULTS: No significant differences between the groups in final vaginal length and diameter were found. However, the VD+RF group exhibited a significant increase in vaginal length during sessions compared to the VD group. Improved comfort and reduced pain during dilation in the VD+RF group were attributed to the thermal effects of RF, which enhanced tissue elasticity and extensibility. Pain reduction during dilation was reported by all participants in the VD+RF group, whereas issues such as canal stenosis and emotional challenges were noted in both groups. The Visual Analog Scale for Satisfaction showed a significant improvement in sexual satisfaction in the VD+RF group compared to the VD group (P = .0422). Although the Female Sexual Function Index questionnaire revealed improvements in sexual function domains, it was only administered to a subset of sexually active women in the RF group.
CONCLUSION: RF is as a safe and effective adjunct to vaginal dilation, enhancing pain management and sexual satisfaction.
METHODS: Ten patients were divided into 2 groups: 5 received RF combined with dilation (VD+RF group), and 5 underwent only vaginal dilation (VD group). The RF treatment involved applying radiofrequency at 39°C for 5 minutes before dilation, while the VD group had dilation alone for 20 minutes.
RESULTS: No significant differences between the groups in final vaginal length and diameter were found. However, the VD+RF group exhibited a significant increase in vaginal length during sessions compared to the VD group. Improved comfort and reduced pain during dilation in the VD+RF group were attributed to the thermal effects of RF, which enhanced tissue elasticity and extensibility. Pain reduction during dilation was reported by all participants in the VD+RF group, whereas issues such as canal stenosis and emotional challenges were noted in both groups. The Visual Analog Scale for Satisfaction showed a significant improvement in sexual satisfaction in the VD+RF group compared to the VD group (P = .0422). Although the Female Sexual Function Index questionnaire revealed improvements in sexual function domains, it was only administered to a subset of sexually active women in the RF group.
CONCLUSION: RF is as a safe and effective adjunct to vaginal dilation, enhancing pain management and sexual satisfaction.